磁共振成像
磁共振成像
자공진성상
CHINESE JOURNAL OF MAGNETIC RESONANCE IMAGING
2014年
4期
274-278
,共5页
付姣慧%常晓丹%王盈盈%姚长丽
付姣慧%常曉丹%王盈盈%姚長麗
부교혜%상효단%왕영영%요장려
乳腺肿瘤%磁共振成像%分子生物学
乳腺腫瘤%磁共振成像%分子生物學
유선종류%자공진성상%분자생물학
Breast neoplasms%Magnetic resonance imaging%Mlcular biology
目的:通过分析乳腺癌MRI表现与术后ER、PR、C-erbB-2、Ki-67、TopoⅡα等分子表达的相关性,初步探讨MRI反映乳腺癌分子生物学变化的可能性。材料与方法回顾性分析156例国人原发性乳腺癌的MRI影像特征,用数据系统(BI-RADS)记录乳腺癌的形态学和血流动力学,用免疫组织化学PS法测定肿瘤组织ER、PR、C-erbB-2、TopoⅡα及Ki-67的蛋白表达。通过Pearson卡方检验分析病灶的形态、形状、边缘、强化方式及时间信号曲线形态与各蛋白表达间的相关性,用Spearman等级相关法分析达峰时间、最大强化率与各生物学因子之间的关系。结果乳腺癌MRI肿块型病变易有TopoⅡα表达;非肿块型病变、不规则病灶及内部均匀强化病变易有C-erbB-2表达;环形强化病变不易有PR表达;最大强化率高的肿瘤易有C-erbB-2表达;达峰时间短的肿瘤易有TopoⅡα、Ki-67表达。结论 MRI影像特征可初步预测乳腺癌部分生物因子的表达状况。
目的:通過分析乳腺癌MRI錶現與術後ER、PR、C-erbB-2、Ki-67、TopoⅡα等分子錶達的相關性,初步探討MRI反映乳腺癌分子生物學變化的可能性。材料與方法迴顧性分析156例國人原髮性乳腺癌的MRI影像特徵,用數據繫統(BI-RADS)記錄乳腺癌的形態學和血流動力學,用免疫組織化學PS法測定腫瘤組織ER、PR、C-erbB-2、TopoⅡα及Ki-67的蛋白錶達。通過Pearson卡方檢驗分析病竈的形態、形狀、邊緣、彊化方式及時間信號麯線形態與各蛋白錶達間的相關性,用Spearman等級相關法分析達峰時間、最大彊化率與各生物學因子之間的關繫。結果乳腺癌MRI腫塊型病變易有TopoⅡα錶達;非腫塊型病變、不規則病竈及內部均勻彊化病變易有C-erbB-2錶達;環形彊化病變不易有PR錶達;最大彊化率高的腫瘤易有C-erbB-2錶達;達峰時間短的腫瘤易有TopoⅡα、Ki-67錶達。結論 MRI影像特徵可初步預測乳腺癌部分生物因子的錶達狀況。
목적:통과분석유선암MRI표현여술후ER、PR、C-erbB-2、Ki-67、TopoⅡα등분자표체적상관성,초보탐토MRI반영유선암분자생물학변화적가능성。재료여방법회고성분석156례국인원발성유선암적MRI영상특정,용수거계통(BI-RADS)기록유선암적형태학화혈류동역학,용면역조직화학PS법측정종류조직ER、PR、C-erbB-2、TopoⅡα급Ki-67적단백표체。통과Pearson잡방검험분석병조적형태、형상、변연、강화방식급시간신호곡선형태여각단백표체간적상관성,용Spearman등급상관법분석체봉시간、최대강화솔여각생물학인자지간적관계。결과유선암MRI종괴형병변역유TopoⅡα표체;비종괴형병변、불규칙병조급내부균균강화병변역유C-erbB-2표체;배형강화병변불역유PR표체;최대강화솔고적종류역유C-erbB-2표체;체봉시간단적종류역유TopoⅡα、Ki-67표체。결론 MRI영상특정가초보예측유선암부분생물인자적표체상황。
Objective:By analying the relationship of MR images to the expressions of ER, PR, C-erbB-2, Ki-67, Topo IIα, and discuss the possibility of MR images used to indicate the expressions of some proteins as biomarkers of breast cancers detected immunohistochemically. Materials and Methods: Retrospective analysis the MRI features of 156 primary breast cancer patients in China was performed. Morphologic and kinetic features of breast cancer in MRI were determined based on the breast imaging and reporting data system (BI-RADS). The expressions of estrogen receptor (ER), progesterone receptor (PR), C-erbB-2, Ki-67 and Topo II α were detected by immunohistochemistry. Pearsonχ2 test and Spearman test were used to analyze the correlations of the MR features to these biomarkers. Results:Topo II α were often expressed in mass-like lesions. C-erbB-2 were often expressed in non-mass-like lesions, irregular shape lesions and homogenous enhancement lesions. PR were poorly expressed in rim enhancement lesions. C-erbB-2 were often expressed in the tumors with higher maximum signal enhancement ratio. Topo II α and Ki-67 were often expressed in the tumors with short time to peak. Conclusion:The present MR data might be expected to being useful in assessing the protein expression of primary breast cancer.